These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3012164)

  • 1. Comparison of acute hemodynamic effects of MC-838, a new angiotensin-converting enzyme inhibitor, with captopril in anesthetized dogs.
    Noguchi K; Kato T; Sunagawa R; Miyamoto Y; Sakanashi M
    Jpn J Pharmacol; 1986 Mar; 40(3):373-80. PubMed ID: 3012164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative cardiovascular effects of a novel angiotensin converting enzyme inhibitor altiopril calcium (MC-838) and captopril in spontaneously hypertensive rats.
    Akima M; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1988; 292():223-36. PubMed ID: 3293543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
    Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responses of renal, coronary and vertebral vasculatures to MC-838 and captopril in anesthetized dogs.
    Noguchi K; Kato T; Sunagawa R; Sakanashi M
    Pharmacology; 1987; 34(1):48-56. PubMed ID: 3033709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue angiotensin-converting enzyme blockade by MC-838 (altiopril calcium) infused intravenously to miniature pigs: comparison with captopril.
    Sakai K; Shiraki Y; Akima M; Imagawa J; Hinohara Y; Koga T; Ichihara T; Tohira Y
    Arch Int Pharmacodyn Ther; 1988; 294():228-40. PubMed ID: 2852930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intracoronary captopril on coronary blood flow and regional myocardial function in dogs.
    Noguchi K; Kato T; Ito H; Aniya Y; Sakanashi M
    Eur J Pharmacol; 1985 Mar; 110(1):11-9. PubMed ID: 3891380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of a phosphorus-containing novel angiotensin converting enzyme inhibitor, SQ 29 852 in anesthetized dogs.
    Ohara N; Yokota S; Konishi C; Shukunobe K; Ono H
    J Pharmacobiodyn; 1991 Dec; 14(12):655-62. PubMed ID: 1812274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Converting enzyme inhibition and modulation of plasma renin activity with captopril in anesthetized rats.
    Suzuki M; Satoh S
    Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):121-36. PubMed ID: 6275810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition.
    Clappison BH; Anderson WP; Johnston CI
    Kidney Int; 1981 Nov; 20(5):615-20. PubMed ID: 6283229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
    Sweet CS; Arbegast PT; Gaul SL; Blaine EH; Gross DM
    Eur J Pharmacol; 1981 Dec; 76(2-3):167-76. PubMed ID: 6174351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
    Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
    J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals.
    Takeyama K; Minato H; Nakatsuji K; Suzuki H; Nose I; Oka M; Hosoki K; Hatano N; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):69-73. PubMed ID: 3513779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased or decreased thirst caused by inhibition of angiotensin-converting enzyme in the rat.
    Evered MD; Robinson MM
    J Physiol; 1984 Mar; 348():573-88. PubMed ID: 6325675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of inhibition of angiotensin I converting enzyme with SQ-14225 on the arterial blood pressure of mongrel dogs.
    Jandhyala BS; Washington GF; Lokhandwala MF
    Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):257-65. PubMed ID: 216064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood.
    Matsuno Y; Taira N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):55-62. PubMed ID: 3513777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs.
    Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
    Arzneimittelforschung; 1985; 35(10):1502-7. PubMed ID: 3000389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo comparison of the renin inhibitor H77 with the angiotensin-converting enzyme inhibitor captopril.
    Oldham AA; Arnstein MJ; Major JS; Clough DP
    J Cardiovasc Pharmacol; 1984; 6(4):672-7. PubMed ID: 6206324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the mechanism of acute decrease of blood pressure induced by captopril (SQ 14,225) in dogs by the use of aprotinin, SAR1-ILE8-angiotensin II and indomethacin.
    Ohara N; Ono H; Hashimoto K
    Jpn Circ J; 1981 Jun; 45(6):672-9. PubMed ID: 6165844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mechanism of the hypotensive action of SQ-14225, an angiotensin-converting enzyme inhibitor in anesthetized dogs.
    Jandhyala BS; Nandiwada P; Buckley JP; Lokhandwala MF
    Res Commun Chem Pathol Pharmacol; 1979 Sep; 25(3):429-46. PubMed ID: 228363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain converting enzyme inhibition: a possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive rats.
    Unger T; Kaufmann-Bühler I; Schölkens B; Ganten D
    Eur J Pharmacol; 1981 Apr; 70(4):467-78. PubMed ID: 6263638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.